Urinalysis Market size worth US$7.088 billion by 2030

Urinalysis Market

The global urinalysis market is expected to grow at a compound annual growth rate of 6.44% over the forecast period to reach a market size of US$7.088 billion in 2030 from US$4.296 billion in 2025.

Urinalysis is a rapid and highly efficient method applied in urine sample testing with the intent of detecting pre-existing chronic conditions including kidney disease and diabetes, as well as infections like urinary tract infections. Numerous physical, microscopic and chemical tests assist in diagnosis through cell counts, protein levels, and creatinine concentrations, as well as the detection of other materials such as crystals in the urine. All these, as implied in their functions, also serve to find the causes of symptoms such as back pain, stomach pain, and painful urination. Based on the increased prevalence of chronic diseases such as diabetes, kidney disease, and urinary tract infections, the market is primed for growth.

Furthermore, the ageing population and increasing government awareness campaigns are likely to push demand for urinalysis along with the latest technological advancements in urinalysis during the forecast period. Ageing populations in both developed and developing countries contribute to the expansion of the urinalysis market. For instance, One in six individuals worldwide will be 60 years of age or older by 2030. At this point, there will be 1.4 billion people over the age of 60, up from 1 billion in 2020. The number of people in the world who are 60 years of age or older is expected to double to 2.1 billion by 2050. Between 2020 and 2050, the population of people 80 years of age or older is predicted to triple, reaching 426 million.

Moreover, one in five adults over 65 has diabetes, according to the International Diabetes Organization. As more disorders are being diagnosed and treated, prescriptions for tests like creatinine, albumin, glucose, ketones, and bilirubin, among others, are increasing. This is good for urinalysis, which is used to perform these tests.

Additionally, one of the main factors propelling the market forward is the higher incidence of urinary tract infections (UTIs) in developing countries. One of the main factors propelling the market expansion is the fact that, if untreated, urinary tract infections (UTIs) can spread to the kidneys and result in birth complications in expectant mothers. Additionally, the 13.3 million people who experience acute kidney injury (AKI) worldwide each year run the risk of developing chronic kidney disease (CKD) or renal failure in the years to come, which is anticipated to drive market growth. Furthermore, it is anticipated that the technological advancements in urine analyzers will present prospective avenues for the expansion of the urinalysis market in the upcoming years.

The global urinalysis market is segmented by product type into two major categories: Instruments and consumables where the instrument is further segmented into automated urine analyzer, semi-automated urine analyzer, and point-of-care urine analyzer, consumables are further segmented into reagents, kits. Dipsticks, and disposables. The rising requirement and repeated purchases of the reagents and dipsticks by hospital and clinical laboratories account for most of the demand for consumables. Dipsticks, which obtain the maximum share of market consumption, are by far the most widely used urinalysis consumable. Reagents are used to quantify the relative concentrations of specific constituents in the urine. However, such convenience and accessibility innovative consumables like point-of-care testing devices and rapid test kits create, further fueling the accessibility and convenience that urinalysis contributes to. Multiple major providers like Siemens Healthcare GmBH, Abbott, and Roche are currently offering high-quality urinalysis test consumables in the market, which is expected to boost the growth of this segment.

The global urinalysis market by test type is segmented into biochemical urinalysis, pregnancy & fertility urinalysis, and sediment urinalysis. A urine test can detect pregnancy, dehydration, kidney and bladder infections, and preeclampsia. Blood sugar test results might show that gestational diabetes could be revealed during the 20th week of pregnancy. Pregnancy tests look for the presence of human chorionic gonadotropin (hCG) hormone which occurs in women’s bodies during pregnancy. With these tests, hCG can be detected in either urine or blood. Pregnancy urine tests are cheap and readily available in every home. When done properly, those home pregnancy tests can be pretty accurate. Development in the Segment will be due to increasing urinalysis demand for pregnancy and fertility detection. There have been numerous studies performed to assess how urinalysis can identify pregnancy.

The global urinalysis market by application is segmented into urinary tract infections, diabetes, kidney diseases, liver diseases, pregnancy and fertility, and others. Urinalysis has been an essential screening test for diabetes, and one of the main engine drivers in market growth is the increasing number of diabetic patients everywhere. Obesity is the biggest risk factor for developing a type 2 diabetic condition. The increasing incidence of obesity in the population in recent decades has been the foremost contributor to the increasing cases of diabetes. Moreover, according to projections by IDF in the year 2014, there will be an estimated number of about 783 million adults – 1 in 8 – living with diabetes by the year 2045. An increase of 46% will be added. The majority of patients, over 90%, are classified as having type 2 diabetes. This type usually develops under the interaction of different factors, such as genetics and the environment, including age as well as demographic and economic status.

The global urinalysis market by end-user is segmented into hospitals & clinics, diagnostic laboratories, research & academic institutions, and home care settings. The developing environment sustained by clinical laboratories increased by easier customer access and newer products. One such clinical test in this context is urinalysis, which is performed in more than 20,000 clinical laboratories across the U.S. Proteomics, genetic testing, microarray technology, biomarkers, and other innovative testing methods have been used in developing the techniques to improve the identification of kidney disease.

Based on geography, the North American region of the global urinalysis market is growing significantly. The North American market is anticipated to hold a substantial market position because of the ageing population and the high prevalence of chronic kidney disease. CKD is associated with diabetes, high blood pressure, and kidney failure. The National Kidney Foundation reports that each year, CKD claims more lives than prostate and breast cancer combined. Kidney disease is a leading cause of death in the United States. About one in five adults with high blood pressure and one in three people with diabetes have kidney disease. As a result, there is an increasing need for precise CKD diagnosis and treatment, which will probably increase the need for urinalysis.

As a part of the report, the major players operating in the Global urinalysis market that have been covered are ARKRAY, Inc., 77 Elektronika Kft., Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Abbott Laboratories, Sysmex Corporation, Neomedica d.o.o. Mindray Medical International Limited, Analis sa/NV.

View a sample of the report or purchase the complete study at: https://www.knowledge-sourcing.com/report/global-urinalysis-market

The market analytics report segments the global urinalysis market as follows:

  • By Product Type
    • Instruments
      • Automated Urine Analyzer
      • Semi-automated Urine Analyzer
      • Point-of-Care Urine Analyzer
    • Consumables
      • Reagents
      • Kits
      • Dipsticks
      • Disposables
  • By Test Type
    • Biochemical Urinalysis
    • Pregnancy & Fertility Urinalysis
    • Sediment Urinalysis
  • By Application
    • Urinary Tract Infections
    • Diabetes
    • Kidney Diseases
    • Liver Diseases
    • Pregnancy and Fertility
    • Others
  • By End-User
    • Hospitals & Clinics
    • Diagnostic Laboratories
    • Research & Academic Institutions
    • Home Care Settings
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Others
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Taiwan
      • Thailand
      • Indonesia
      • Others
  • Tissue Diagnostics Market Report
  • Cancer Diagnostics Market Size
  • Urinary Catheters Market Size